Penn Medicine rolls out personalized diagnostics

Academia is increasingly realizing the medical and financial possibilities that building personalized medicine programs can bring. Case in point: The Perelman School of Medicine at the University of Pennsylvania this year has unveiled the Center for Personalized Diagnostics, a joint initiative from the school's department of Pathology and Laboratory medicine and the Abramson Cancer Center. The center's goal: to have experts in genomic analysis, bioinformatics and cancer genetics work with oncologists who design clinical trials and treat patients in order to test new drugs. The idea is that their work will enable patients to have personalized diagnostics and treatment, by identifying the specific cancer mutation they may have, and then spotting the best possible treatment. Release

Suggested Articles

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.